Menendez slams Hugin for discounting drugs in Russia

PENNINGTON - U.S. Senator Bob Menendez today called Bob Hugin’s decision to sell a life-saving cancer drug in Russia for almost half the U.S. price “outrageous” and “despicable.” The comments by the New Jersey Democrat came a day after NJ.com reported that Celgene, the pharmaceutical company Hugin ran, cut the price of Revlimid by about 45% in Russia while raising the cost of the same drug in the United States